Latest news
ALGS Stock Rallies 16% After-Hours On $25M Cash Boost From China Hepatitis B Drug Deal - StocktwitsStocktwits · Fri, 07 Aug 2026 18:10:26 GMTHepatitis B virus infection or reactivation and HBV-related liver dysfunction in patients with inflammatory bowel disease receiving infliximab: a nationwide real-world study - EurekAlert!EurekAlert! · Thu, 30 Jul 2026 17:55:28 GMTBeyond the birth dose: China's strategic push to curb Hepatitis B - news.cgtn.comnews.cgtn.com · Tue, 28 Jul 2026 07:02:21 GMT